Impact of Dexamethasone Route on Pain and Inflammation in iPACK With ACB for Knee Arthroplasty
CompletedPhase 4NCT07180953
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
"The Effect of Dexamethasone Administration Route on Pain and Inflammatory Response in iPACK With ACB for Total Knee Arthroplasty" - written in plain language according to ClinicalTrials.gov standards: The goal of this clinical trial is to learn how the route of dexamethasone administration (either through the vein or nerve block) affects pain and inflammation in people having total knee replacement surgery. All participants will receive two types of nerve blocks before surgery: an iPACK block and an adductor canal block (ACB), which help control pain after the operation. The main questions the study aims to answer are: Does injecting dexamethasone into the nerve block reduce pain more effectively than giving it by vein? Which method leads to a lower inflammatory response after surgery? Researchers will compare the two groups to see which route offers better pain relief and less swelling after knee surgery. Participants will: Be randomly assigned to receive dexamethasone either in the nerve block or by IV Receive standard care for total knee replacement Rate their pain and have blood tests after surgery to measure inflammation
Study details
- Official title
- Route of Dexamethasone Administration in iPACK and ACB for Total Knee Replacement: A Randomized Trial
- Conditions
- Osteoarthritis, Knee
- Knee Pain Chronic
- Arthropathy of Knee
- Interventions
- Drug: NaCl 0.9%
- Drug: Dexamethasone 4mg
- Drug: Dexamethasone 4mg
- Sponsor
- Poznan University of Medical Sciences
- Start date
- 2025-09-13
- Primary completion
- 2026-03-01
- Sex
- All
- Age range
- from 65 Years to 100 Years
- Results posted
- No results posted in this snapshot
- Countries
- Poland
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * patients scheduled for total knee arthroplasty * patients aged \>65 and \<100 years * patients can provide informed consent * patients can reliably report symptoms to the research team Exclusion Criteria: * inability to provide first-party consent due to cognitive impairment or a * language barrier * infection at the site of the regional block, * coagulation disorders, * immunodeficiency, * American Society of Anesthesiologists (ASA) physical status of IV or higher, * history of regular steroid medication.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT07180953